Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic ...
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
Livestrong.com on MSN2 天
Phenylephrine for Colds: Why It Doesn’t Work and What You Should Use Instead
Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...